TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, cilt.44, sa.6, ss.287-294, 2016 (ESCI)
Objective: Paclitaxel is used in the treatment of cancer, and it may cause interleukin-1 beta (IL-1 beta)-related peripheral neuropathic pain. While our primary aim was to investigate the analgesic efficacy of an IL-1 beta antagonist, a secondary outcome was to assess whether a correlation exists between analgesic effects and antioxidant activity.